NR4A1 and triple-negative breast carcinoma: Similar to the aforementioned data for the 13C-pyruvate labeling experiments, the triple-negative breast cancer cell line MDA-MB-231 displayed different 13C-glutamine metabolism from that shown by hormone receptor-positive MCF7 cell subtype (Figure 6B).